PortfoliosLab logoPortfoliosLab logo

Sharpe ratio is not yet available for CURLF. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.

How it compares to other similar stocks

The table compares Curaleaf Holdings, Inc.'s Sharpe Ratio with other stocks in the Drug Manufacturers - Specialty & Generic industry across multiple time periods, showing how CURLF's risk-adjusted performance compares to industry peers.

Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jun 24, 2026.


SymbolName1Y Sharpe Ratio5Y Sharpe Ratio10Y Sharpe RatioAll Time Sharpe Ratio
BIOABioAge Labs, Inc5.01
IRWDIronwood Pharmaceuticals, Inc.4.72
INDVIndivior PLC Ordinary Shares4.71
AMRXAmneal Pharmaceuticals, Inc.3.44
ETONEton Pharmaceuticals Inc2.73
VTRSViatris Inc.2.63
TEVATeva Pharmaceutical Industries Limited2.47
IPSEYIpsen SA ADR2.15
SDZNYSandoz Group AG2.08
ELANElanco Animal Health Incorporated1.67
CURLFCuraleaf Holdings, Inc.

S&P 500 Index

How to choose period

Historical Sharpe Ratio

The chart shows CURLF's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when CURLF consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.


Loading charts...

Sharpe Ratio Calculator

How does CURLF fit in your portfolio?

Add your other holdings to see your portfolio's Sharpe Ratio and find out.

Analyze Your Portfolio